Strategies to Reduce HCV Incidence in At-Risk European Populations

This downloadable slideset reviews the importance of treatment as prevention in achievement of HCV elimination goals in Europe and provides practical strategies for implementing treatment and support services in PWID and those in the correctional setting.
Graham R. Foster, FRCP, PhD
Program Director
Format: Microsoft PowerPoint (.ppt)
File Size: 4.82 MB
Released: March 27, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
INHSU Logo
Supported by an educational grant from
Gilead Sciences

Related Content

Complimentary slides from CCO featuring an in-depth analysis of HCV burden and care disparities in specific populations and strategies to reduce disparities.

Released: December 1, 2021

Expert insights on special considerations for individuals with HCV in ethnically diverse populations, from Ahmed M. Elsharkawy PhD, FRCP(UK), and Clinical Care Options (CCO)

person default Ahmed M. Elsharkawy, PhD, FRCP(UK) Released: December 1, 2021

Clinical Care Options (CCO) podcast with Dr. Nancy Reau on new viral hepatitis data from AASLD 2021, including HBV, HCV, and hepatitis delta

Nancy Reau, MD Released: December 1, 2021

Clinical Care Options (CCO) expert analysis by Dr. Stefan Zeuzem on new viral hepatitis data from AASLD 2021, including HBV, HCV, and hepatitis delta

Stefan Zeuzem, MD Released: November 30, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue